Abundance of EGFR signaling due to increased receptor expression and subsequent ligand-induced overstimulation of the EGFR pathway therefore seems to be a major negative selector for EGFR-amplified GBM cells in vitro. The gene discussed is EGFR; the disease is glioblastoma.